Mechanisms of Genotoxicity and Proteotoxicity Induced by the Metalloids Arsenic and Antimony
Overview
Affiliations
Arsenic and antimony are metalloids with profound effects on biological systems and human health. Both elements are toxic to cells and organisms, and exposure is associated with several pathological conditions including cancer and neurodegenerative disorders. At the same time, arsenic- and antimony-containing compounds are used in the treatment of multiple diseases. Although these metalloids can both cause and cure disease, their modes of molecular action are incompletely understood. The past decades have seen major advances in our understanding of arsenic and antimony toxicity, emphasizing genotoxicity and proteotoxicity as key contributors to pathogenesis. In this review, we highlight mechanisms by which arsenic and antimony cause toxicity, focusing on their genotoxic and proteotoxic effects. The mechanisms used by cells to maintain proteostasis during metalloid exposure are also described. Furthermore, we address how metalloid-induced proteotoxicity may promote neurodegenerative disease and how genotoxicity and proteotoxicity may be interrelated and together contribute to proteinopathies. A deeper understanding of cellular toxicity and response mechanisms and their links to pathogenesis may promote the development of strategies for both disease prevention and treatment.
Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic transport.
Lorentzon E, Lee J, Masaryk J, Keuenhof K, Karlsson N, Galipaud C bioRxiv. 2025; .
PMID: 39868121 PMC: 11761705. DOI: 10.1101/2025.01.13.632748.
Comparative Proteome-Wide Abundance Profiling of Yeast Strains Deleted for Cdc48 Adaptors.
Rossio V, Paulo J Proteomes. 2024; 12(4).
PMID: 39585118 PMC: 11587464. DOI: 10.3390/proteomes12040031.
Zbieralski K, Staszewski J, Konczak J, Lazarewicz N, Nowicka-Kazmierczak M, Wawrzycka D Int J Mol Sci. 2024; 25(8).
PMID: 38674035 PMC: 11050377. DOI: 10.3390/ijms25084450.
Yang Y, Li Y, Li R, Wang Z Front Pharmacol. 2024; 15:1338725.
PMID: 38495096 PMC: 10943982. DOI: 10.3389/fphar.2024.1338725.